MWNA
PAHC icon

Marshall Wace North America’s Phibro Animal Health PAHC Stock Holding History

Marshall Wace North America’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,345
Closed -$50K – 1519
2019
Q3 		$50K Sell
2,345
-4,774
-67% -$131K ﹤0.01% 1161
2019
Q2 		$226K Buy
7,119
+786
+12% +$24.6K ﹤0.01% 1019
2019
Q1 		$209K Hold
6,333
– – ﹤0.01% 979
2018
Q4 		$204K Buy
+6,333
New +$239K ﹤0.01% 954

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace North America's PAHC Position: Q4 2019 in Review

Marshall Wace North America sold out of Phibro Animal Health (PAHC) in Q4 2019, closing a stake of 2,345 shares — an estimated $50K sold.

Marshall Wace North America first reported a position in PAHC in Q4 2018 and held it in 4 quarters. The position peaked at $226K in Q2 2019. 155 funds tracked by Wall St. Rank hold PAHC as of Q4 2019.

  • Marshall Wace North America reported no remaining Phibro Animal Health position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace North America sold 2,345 Phibro Animal Health shares in Q4 2019, an estimated $50K.
  • Marshall Wace North America first reported a position in Phibro Animal Health in Q4 2018 and held it in 4 quarters.
  • Marshall Wace North America's Phibro Animal Health position peaked at $226K in Q2 2019.
  • 155 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.